Navigation Links
HeartWare Completes GLP Studies of Next Generation MVAD® Pump; Data Presented Today at ISRBP Congress
Date:9/9/2011

th a newly designed controller, early next year.  We look forward to exploring the potential of the MVAD Pump for both left and right ventricular support, as well as the potential to benefit smaller-sized patients or those with smaller hearts, including pediatric patients."

About the MVAD System

The MVAD Pump is designed to require less invasive surgery than that required to implant currently available devices.  In particular, the MVAD Pump is expected to be implanted without the need for a median sternotomy of the rib cage, as was demonstrated during the preclinical study presented today.  By reducing the invasiveness of the surgery, HeartWare hopes to be able to treat a greater proportion of heart failure patients.

The MVAD Pump has been shown over a series of pre-clinical studies to have comparable blood flow characteristics to the Company's HVAD Pump.  

More than 750 patients across Europe have received the HeartWare Ventricular Assist System, which features the HVAD Pump, a left ventricular assist device designed to provide circulatory support for patients in the advanced stage of heart failure.  A proprietary continuous flow pump, the HVAD Pump is capable of delivering up to 10 litres of blood per minute and is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices.  

Highlighting HVAD at ISRBP

"In addition to Dr. McGee's presentation on the MVAD GLP studies, there were four other presentations on the HeartWare Ventricular Assist System.  These highlighted many of the novel attributes of the HVAD platform such as wave form capabilities, flow estimation advances, self-regulating behavior and pump performance during exercise," added Mr. Godshall.  "The broad spectrum of presentations demonstrate both the Company's technology leadership in mechanical circulatory support, which extends beyond the HV
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. HeartWare to Report 2010 Fourth Quarter and Year-End Financial Results
2. HeartWare to Present at the 22nd Annual Piper Jaffray Health Care Conference
3. HeartWare International, Inc. Temporary Suspension of Trading
4. U.S. Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International
5. Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc
6. TWi Biotechnology Successfully Completes Patient Recruitment for Phase IIb Trial of AC-201 for the Treatment of Type II Diabetes
7. Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers
8. AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API
9. Peloton Therapeutics Completes $18 Million Series A Financing
10. Sinapis Pharma Completes Phase I Trial
11. MiMedx Group Completes $5,000,000 Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Terascala, the industry leader in ... a former vice president of product management for Flexera ... of marketing. Terascala’s software when combined with leading compute ... highest performance and most reliable solutions for processing big ... channel expansion and broaden its product portfolio. His leadership ...
(Date:7/10/2014)... 2014 Senior supply chain management executives ... addressed the challenges of “Reducing Cost, Lead Time, & ... strategic sourcing. Describing the partnership of the Bio Supply ... Management Institute ( SCMI) of the University of ... at the Kroc Institute of Peace and Justice in ...
(Date:7/10/2014)... , July 10, 2014 Research and ... of the "International Photonic Integrated Circuit (Monolithic ... to 2019" report to their offering. ... The concept of photonic integration traces its roots ... The promise of photonic integration went unexplored and ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Time of day crucial to accurately test for diseases, new research finds 2
... Accounting Oversight Board (PCAOB) will place a greater ... numerous studies, including our own, that show IT change ... the investment to fix your change management process because ... compliance program. , ,PCAOB Release number 2006-007, a ...
... Wis. - Perscitus Biosciences, a Madison biotechnology company, ... Department of Commerce . , ,Perscitus Biosciences was ... based on reactive oxygen biochemistry. James Thomas, CEO and ... be used to purchase equipment and hire researchers to ...
... what many deemed a historic meeting between Steve Jobs ... Wall Street Journal's schmooze-fest titled D: All Things Digital. While ... Age were cordial and humble (a word I have not often ... of competition and cooperation in the most mutually complimentary terms (you ...
Cached Biology Technology:Why IT change management is more important than ever 2Why IT change management is more important than ever 3Why IT change management is more important than ever 4What if Jobs and Gates had teamed up? 2What if Jobs and Gates had teamed up? 3What if Jobs and Gates had teamed up? 4
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
(Date:7/10/2014)... Mass. , June 30, 2014  Aware, Inc. ... biometrics software and services, previously announced on June 26, ... special cash dividend of $1.75 per share, or approximately ... date of July 10, 2014 and a payment date ... by NASDAQ that it had set an ex-dividend date ...
(Date:7/10/2014)... N.Y. , July 2, 2014 It ... (ABD) to announce the appointment of the world-renowned Thoracic ... Board of Directors. Dr. Ginsburg, with over ... facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical ... Pacemaker since the late 1980,s and is considered an ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
... There are potentially effective treatments for acute myeloid leukemia ... of cases. In a paper published today in Leukemia ... has pinpointed a protein that could play a key, previously ... new information in the quest to treat and cure childhood ...
... Complex heritable traits are not only determined by changes ... Groningen Bioinformatics Centre, together with their French colleagues, have ... flowering time and architecture in plants. Furthermore, these marks ... manner. Their results were published in Science ...
... will be equipped with a new, online information system ... disorders, thanks to 3.5m European Union funding for EMBalance. ... involve researchers from ten different partners, spread across seven ... dizziness etc.) affect more than a third of the ...
Cached Biology News:New target isolated for leukemia drug development 2Revolutionary new view on heritability in plants 2Revolutionary new view on heritability in plants 3€3.5m to improve diagnosis of balance disorders 2
... Disruption of the mitochondrial transmembrane potential ... events that occur following induction of ... Kit utilizes a lipophilic cation, termed ... marker. MitoLight is a mitochondrial dye ...
... Detection Kit contains a green fluorescent-labeled inhibitor, ... of valylalanylaspartic acid (VAD) fluoromethyl ketone (FMK), ... When added to a population of cells, ... and covalently binds to a reactive cysteine ...
... ChipWriter Pro system, 220-240 V, uses floating ... oligonucleotides, carbohydrates, lipids, and other biomolecules onto ... This system can generate high-density arrays with ... or greater than 57,000 spots per membrane ...
... arrays have been developed for affinity ... A variety of ProteinChip chemical surfaces ... to their unique biochemical properties. Each ... side-by-side sample comparison, and the chips ...
Biology Products: